What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Major depressive disorder
- Psychiatry
A. John Rush mostly deals with Psychiatry, Major depressive disorder, Depression, Bipolar disorder and Internal medicine.
The study incorporates disciplines such as Randomized controlled trial and Clinical psychology in addition to Psychiatry.
His Major depressive disorder research is multidisciplinary, incorporating perspectives in Quality of life, Anxiety, Citalopram, STAR*D and Prospective cohort study.
His Depression research includes elements of Pharmacotherapy and Clinical trial.
The concepts of his Bipolar disorder study are interwoven with issues in Schizophrenia and Cohort study.
His Internal medicine study combines topics in areas such as Antidepressant, Endocrinology and Oncology.
His most cited work include:
- The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. (2157 citations)
- Diagnosis and Treatment of Depression in Late Life (695 citations)
- Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. (571 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Psychiatry, Depression, Major depressive disorder, Internal medicine and Clinical psychology.
Within one scientific family, A. John Rush focuses on topics pertaining to Randomized controlled trial under Psychiatry, and may sometimes address concerns connected to Anesthesia.
His Depression course of study focuses on Sleep in non-human animals and Electroencephalography and Audiology.
A. John Rush interconnects Antidepressant, Citalopram, Mental health, Severity of illness and Comorbidity in the investigation of issues within Major depressive disorder.
His studies in Internal medicine integrate themes in fields like Placebo and Endocrinology.
His Clinical psychology study integrates concerns from other disciplines, such as Cognitive therapy and Cognition.
He most often published in these fields:
- Psychiatry (61.63%)
- Depression (44.36%)
- Major depressive disorder (35.25%)
What were the highlights of his more recent work (between 2008-2021)?
- Psychiatry (61.63%)
- Depression (44.36%)
- Major depressive disorder (35.25%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Psychiatry, Depression, Major depressive disorder, Internal medicine and Clinical psychology.
His Psychiatry study combines topics from a wide range of disciplines, such as Odds ratio and Clinical trial.
His Depression research incorporates elements of Young adult, Severity of illness, Psychometrics and Rating scale.
His research investigates the connection between Psychometrics and topics such as Personality Assessment Inventory that intersect with issues in Item response theory, Classical test theory, Mass screening and Hamilton Rating Scale for Depression.
His Major depressive disorder research integrates issues from Bipolar disorder, Adverse effect, Anxiety, Substance abuse and Cohort.
The various areas that A. John Rush examines in his Internal medicine study include Escitalopram, Anterior cingulate cortex, Placebo, Sertraline and Depressive symptoms.
Between 2008 and 2021, his most popular works were:
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the Acute and Continuation Treatment of Unipolar Depressive Disorders (298 citations)
- Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report. (169 citations)
- Cross-disorder genomewide analysis of schizophrenia, bipolar disorder, and depression. (166 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Major depressive disorder
- Psychiatry
His primary scientific interests are in Psychiatry, Major depressive disorder, Depression, Citalopram and Internal medicine.
His work on Antidepressant and Mental health as part of general Psychiatry research is frequently linked to Genome-wide association study, thereby connecting diverse disciplines of science.
His research integrates issues of Psychometrics, Bipolar disorder, Randomized controlled trial, Quality of life and Cohort in his study of Major depressive disorder.
His work deals with themes such as Young adult, Severity of illness, Substance abuse and Clinical psychology, which intersect with Depression.
In his research on the topic of Clinical psychology, Alcohol abuse and Comorbidity is strongly related with Anxiety.
His Citalopram study integrates concerns from other disciplines, such as Trial registration and Physical therapy.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
